Journals / Turkish Thoracic Journal / 2017 / Cilt: 18 - Sayı: 1

Pulmonary Mucormycosis Over 130 Years: A Case Report and Literature Review

Pages
1–5
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This article tracks the ever-changing management of pulmonary mucormycosis over the last 130 years, and how this affected mortality.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Mucor is a ubiquitous fungus that belongs to the family of Zygomycetes, though a noninvasive saprophyte in the normal host, it can cause life threatening infections in immunocompromised patients, including angioinvasive pulmonary mucormycosis; a disease notorious for its high mortality.
📊
Key Findings & Data:Mucor is a ubiquitous fungus that belongs to the family of Zygomycetes, though a noninvasive saprophyte in the normal host, it can cause life threatening infections in immunocompromised patients, including angioinvasive pulmonary mucormycosis; a disease notorious for its high mortality.
💡
Conclusion & Impact:This article tracks the ever-changing management of pulmonary mucormycosis over the last 130 years, and how this affected mortality.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Mucor is a ubiquitous fungus that belongs to the family of Zygomycetes, though a noninvasive saprophyte in the normal host, it can cause life threatening infections in immunocompromised patients, including angioinvasive pulmonary mucormycosis; a disease notorious for its high mortality. This article tracks the ever-changing management of pulmonary mucormycosis over the last 130 years, and how this affected mortality.

🔖

Cite This Article

YAMİN, H. S., ALASTAL, A. Y., BAKRİ, I. (2017). Pulmonary Mucormycosis Over 130 Years: A Case Report and Literature Review. Turkish Thoracic Journal, Cilt: 18 - Sayı: 1, 1–5. https://ajindex.com/articles/418071

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Furbringer P. Beobachtungen uber lungenmycose beim menschen. Arch Pathol Anat Physiol Klin Med 1876;66330-65
  2. Baker RD. Mucormycosis-a new disease? JAMA 1957;163:805-8
  3. Baker RD. Mucormycosis. The Pathologic Anatomy of Mycoses Human Infection With Fungi, Actinomyces, and Algae. New York Springer-Verlag NY Inc 1971;832-918
  4. Tedder M, Spratt JA, Anstadt MP, et al. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 1994;57:1044-50. [CrossRef] 5. Lee FY, Mossad SB, Adal KA. Pulmonary mucormycosis: the last 30 years. Arch Intern Med 1999;159:1301-9. [CrossRef] 6. Pacheco P, Ventura AS, Branco T, et al. Clinical Experience in Invasive Fungal Infections. Clinical Drug Investigation. 2013;33(Suppl 1):23-6
  5. Juan YH, Saboo SS, Lin YC, et al. Reverse halo sign in pulmonary mucormyosis. QJM 2014;107:777-8. [CrossRef] 8. Alfageme I, Reina A, Gallego J, et al. Endobronchial instillations of amphotericin B: complementary treatment for pulmonary mucormycosis. J Bronchology Interv Pulmonol 2009;16:214-5. [CrossRef] 9. Patel A, Bishburg E, Nagarakanti S. Mucormycosis in an HIVinfected renal transplant patient: A case report and review of the literature. Am J Case Rep 2014;15:74-8. [CrossRef] 10. Colón-Santos E, González-Ramos M, Bertrán-Pasarell J, et al. Disseminated nocardiosis masking an atypical zygomycosis presentation in a kidney transplant recipient. Transpl Infect Dis 2011;13:380-4. [CrossRef] 11. Bethge WA, Schmalzing M, Stuhler G, et al. Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. Haematologica 2005;90(Suppl):ECR22
  6. Dai Y, Walker JW, Halloush RA, Khasawneh FA. Mucormycosis in two community hospitals and the role of infectious disease consultation: a case series. Int J Gen Med 2013;6:833-8
  7. Leithauser M, Kahl C, Aepinus C, et al. Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation. Transpl Infect Dis 2010;12:251-7. [CrossRef] 14. Capria S, De Angelis F, Gentile G, et al. Complete remission obtained with azacitidine in a patient with concomitant therapy related myeloid neoplasm and pulmonary mucormycosis. Mediterr J Hematol Infect Dis 2013;5:e2013048
  8. Mousset S, Bug G, Heinz WJ, et al. Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation. Transpl Infect Dis 2010;12:261-4. [CrossRef] 16. Kwan LP, Choy CB, Chan TM, et al. Successful treatment of pulmonary rhizopus infection